Skip to main content
AstraZeneca PLC (STO: AZN)
Sweden flag Sweden · Delayed Price · Currency is SEK
1,398.00
+12.00 (0.87%)
Nov 19, 2024, 5:12 PM CET

AstraZeneca Revenue

AstraZeneca had revenue of $13.57B USD in the quarter ending September 30, 2024, with 18.04% growth. This brings the company's revenue in the last twelve months to $51.21B, up 13.81% year-over-year. In the year 2023, AstraZeneca had annual revenue of $45.81B with 3.29% growth.

Revenue (ttm)
$51.21B
Revenue Growth
+13.81%
P/S Ratio
n/a
Revenue / Employee
$569.59K
Employees
89,900
Market Cap
2,129.73B SEK

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202345.81B1.46B3.29%
Dec 31, 202244.35B6.93B18.53%
Dec 31, 202137.42B10.80B40.58%
Dec 31, 202026.62B2.23B9.16%
Dec 31, 201924.38B2.29B10.38%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Swedish Orphan Biovitrum AB (publ) 25.44B
Sectra AB (publ) 3.17B
Getinge AB (publ) 33.59B
Camurus AB (publ) 1.69B
Vitrolife AB (publ) 3.56B
Medicover AB (publ) 22.60B
Elekta AB (publ) 18.12B
Bonesupport Holding AB (publ) 814.46M
Revenue Rankings

AstraZeneca News

More News